THE CAMPAIGN FOR SUSTAINABLE RX PRICING

MMM · Medicare/Medicaid

Prescription drug pricing issues. S. 229 Drug-price Transparency for Consumers (DTC) Act. H.R. 3789 - The Drug-price Transparency for Consumers (DTC) Act.

Literal federal measure citations: S. 229, H.R. 3789

PHA · Pharmacy

Prescription drug pricing issues. H.R. 1843/S. 1032 - Increasing Transparency in Generic Drug Applications Act. S. 1954 - Biosimilar Red Tape Elimination Act; S. 1095 - Stop Stalling Act S. 1067 - Ensuring Timely Access to Generics Act; S. 2630 - REMEDY Act; H.R.1262 - Mikaela Naylon Give Kids a Chance Act.

Literal federal measure citations: H.R. 1843, S. 1032, S. 1954, S. 1095, S. 1067, S. 2630, H.R.1262

CPT · Copyright/Patent/Trademark

Patent abuse issues. S.1040 - Drug Competition Enhancement Act. S.1041 - Affordable Prescriptions for Patients Act. S.1096 - Preserve Access to Affordable Generics and Biosimilars Act. S.1095 - Stop STALLING Act. S. 1097 - Interagency Patent Coordination and Improvement Act of 2025. S. 43 - Skinny Labels, Big Savings Act. H.R. 3269/S. 2276 - ETHIC Act. S. 2658 - Medication Affordability and Patent Integrity Act. H.R. 3160/s. 1533 - the Prevail Act. H.R. 3152/S. 1546 - Patient Eligibility Restoration Act. H.R. 3010/S. 1785 - the No Handouts for Drug Advertisement Act.

Literal federal measure citations: S.1040, S.1041, S.1096, S.1095, S. 1097, S. 43, H.R. 3269, S. 2276, S. 2658, H.R. 3160, s. 1533, H.R. 3152, S. 1546, H.R. 3010, S. 1785